HeartBeat Technologies

Company Overview

Snapshot

Founded in November 2013 by Michael Kasan and Ehud Baron, HeartBeat Technologies operated with 1–10 employees. The company raised $650,000 across four funding rounds from OSR Enterprises and Capital Innovators. In December 2025, HeartBeat Technologies ceased operations.

Business overview

HeartBeat Technologies (HBT) is a medical application software company that develops proprietary machine learning algorithms to generate real-time hemodynamic parameters. Its software integrates with third-party wearable devices to measure biometrics such as continuous blood pressure, cardiovascular indicators, and hydration. HBT offers a product suite including MediBeat Pro, MediBeat, and Beatness mobile applications, which receive data from sensors and pulse oximeters. This data is analyzed by machine learning on HBT's server to display real-time advanced hemodynamic parameters and track changes over time. The solution is designed for healthcare providers and individuals, offering noninvasive care management through a HIPAA and HL7 compliant server, serving the Digital Healthcare and Patient Remote Monitoring sectors.

Strategic signal

HeartBeat Technologies ceased operations in December 2025. This indicates a complete shutdown of the company's activities, signaling to investors and innovation teams that the venture is no longer active in the health tech and life sciences market.

Company Intelligence Q&A

What is the current operational status of HeartBeat Technologies?

HeartBeat Technologies is currently non-active, having ceased operations in December 2025.

When was HeartBeat Technologies founded and by whom?

HeartBeat Technologies was founded in November 2013 by co-founders Michael Kasan and Ehud Baron.

What is HeartBeat Technologies' primary focus?

HeartBeat Technologies focuses on developing mobile application software with proprietary machine learning algorithms to monitor hemodynamic parameters in real time, integrating with wearable devices for health monitoring.

What was a key strategic initiative for HeartBeat Technologies in March 2018?

In March 2018, HeartBeat Technologies partnered with Saint Elizabeth Health Care and Baycrest Health Sciences to test its heart health technology in Canadian seniors care facilities as part of the Canada-Israel Collaboration Program.

Which investors participated in HeartBeat Technologies' funding rounds?

HeartBeat Technologies received funding from investors including OSR Enterprises.